Ascletis Pharma Inc. (OTCMKTS:ASCLF) Short Interest Up 30.0% in January

Ascletis Pharma Inc. (OTCMKTS:ASCLF) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 593,545 shares, an increase of 30.0% from the January 15th total of 456,545 shares. Based on an average daily trading volume, of 3,532 shares, the days-to-cover ratio is currently 168.0 days. Based on an average daily trading volume, of 3,532 shares, the days-to-cover ratio is currently 168.0 days.

Ascletis Pharma Price Performance

Shares of Ascletis Pharma stock opened at $2.10 on Monday. The company’s fifty day simple moving average is $1.76 and its two-hundred day simple moving average is $1.59. Ascletis Pharma has a 12-month low of $0.62 and a 12-month high of $2.29.

About Ascletis Pharma

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).